The world's first and only Automated Sample Prep™ system that collects, enriches, and stores bacterial samples automatically with zero hands on time–enabling faster, more confident diagnoses.
Explore
REINVENTING AN 85 YEAR-OLD SYSTEM
Today, 1 out of every 5 samples is misdiagnosed because samples often arrive to the lab degraded. LabReady re-imagines infection testing by automatically prepping and protecting samples the moment they are collected.
MODERNIZING YOUR TESTING
Since LabReady samples are automatically enriched, all you need to do is run them for diagnosis with any immunoassay or molecular test platform. This huge time-saver means you can improve your testing workflow, increase throughput, and deliver faster diagnoses.
TemperatureIntegrity
Enrichment DuringTransport
Cold-ChainElimination
Lab CultureReady
TemperatureIntegrity
Enrichment DuringTransport
Cold-ChainElimination
Lab CultureReady
Enrichment During Transport
Temperature Integrity
Eliminates Cold-Chain Costs
Lab Culture Ready
By integrating our Specimen Multiplier Technology™ into a transport system, we’vecreated an entirely new method of faster, morereliable diagnoses when it is most critical.
It's not a new lab procedure. It's the first fully integrated specimen enrichment transport system.
By integrating our Specimen Multiplier Technology™ into a transport system, we’ve created an entirely new method of faster, more reliable diagnoses when it is most critical.
FOR PATIENTS
LabReady’s Group B Strep product is the first in our line of women’s health diagnostics that helps avoid life-threatening complications and expensive consequences for mothers and their babies.
Patients
Patients
.png)
We’ll be in touch soon.
In the mean time learn more about LabReady’s mission to decrease global infection mortality.
Labready Mission
If you’d like to chat about LabReady in more detail, complete this form and we’ll get back to you.
† LabReady is currently CE marked as a medical device to detect infections in pregnant women
and is under review by the FDA as a Class 1 non-exempt medical device for medical use in the US market.
† LabReady is currently CE marked as a medical device to detect infections in pregnant women
and is under review by the FDA as a Class 1 non-exempt medical device for medical use in the US market.
† LabReady is currently CE marked as a medical device to detect infections in pregnant women and is under review by the FDA as a Class 1 non-exempt medical device for medical use in the US market.
